Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
Robertson
L E
LE
University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Keating
M J
MJ
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate